Arrogene
Santa Monica
About Arrogene
Arrogene is a developer of a cancer medical technology designed to create a new generation of nano agents capable of delivering peptide, protein, and oligonucleotide therapeutics across the blood-brain barrier. The company's technology offers a unique nano-medicine platform that delivers multiple tumor inhibitors or imaging agents and is being tailored to fight different types of cancer, enabling patients to prevent tumor growth for imaging.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.9M
- Last round: Series Unknown (May 2018)
- Website: arrogene.com
- Phone: +1-424-238-4442
Industries & Categories
Biotechnology, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/arrogene-13096 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.